Cystic Fibrosis Therapeutics Market
Cystic Fibrosis Therapeutics Global Strategic Business Report 2023-2030 Featuring Key Players - AbbVie, Galapagos, Genentech, Gilead Sciences, Novartis, and Vertex Pharmaceuticals
13 juin 2024 05h42 HE | Research and Markets
Dublin, June 13, 2024 (GLOBE NEWSWIRE) -- The "Cystic Fibrosis Therapeutics - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for...
Pharyngitis Market
Pharyngitis Market Report, 2024-2034: Epidemiology Insights, Industry Trends, Drug Sales, Opportunities and Forecasts
13 juin 2024 04h05 HE | Research and Markets
Dublin, June 13, 2024 (GLOBE NEWSWIRE) -- The "Pharyngitis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034" report has been added to ...
Emphysema Market
Emphysema: Market Trends, Epidemiology, Marketed & Pipeline Drugs, Unmet Needs, Competitive Landscape, and SWOT Analysis 2024-2034
07 juin 2024 09h45 HE | Research and Markets
Dublin, June 07, 2024 (GLOBE NEWSWIRE) -- The "Emphysema Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034" report has been added to ...
22157.jpg
Pneumonia Market and Epidemiology Insights 2018-2023 and Outlook 2024-2034 - Featuring Allergan/Pfizer, Merck Sharp and Dohme, Shionogi, Paratek Pharma, Nabriva Therapeutics, and More
06 juin 2024 11h05 HE | Research and Markets
Dublin, June 06, 2024 (GLOBE NEWSWIRE) -- The "Pneumonia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034" report has been added to ...
Global Dry Powder Inhaler Market
Dry Powder Inhaler Global Market Report 2024: A $25.82 Forecasted Market by 2028
04 juin 2024 04h01 HE | Research and Markets
Dublin, June 04, 2024 (GLOBE NEWSWIRE) -- The "Dry Powder Inhaler Global Market Report 2024" has been added to ResearchAndMarkets.com's offering.The dry powder inhaler market size has grown...
22157.jpg
Alpha-1 Antitrypsin Deficiency Market and Epidemiology Forecast to 2032
21 mai 2024 04h02 HE | Research and Markets
Dublin, May 21, 2024 (GLOBE NEWSWIRE) -- The "Alpha-1 Antitrypsin Deficiency Market Insight, Epidemiology and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offeringA...
22157.jpg
Respiratory Collaboration, R&D, and Licensing Deals Trends Report 2024
07 mai 2024 09h08 HE | Research and Markets
Dublin, May 07, 2024 (GLOBE NEWSWIRE) -- The "Respiratory Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering.Respiratory Collaboration and...
22157.jpg
Alpha-1 Antitrypsin Deficiency Epidemiology Insights and Forecasts, 2019-2022 & 2023-2032: Focus on United States, EU4 (Germany, France, Italy, Spain) and the United Kingdom, and Japan
30 avr. 2024 04h22 HE | Research and Markets
Dublin, April 30, 2024 (GLOBE NEWSWIRE) -- The "Alpha-1 Antitrypsin Deficiency - Epidemiology Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This 'Alpha-1 Antitrypsin...
22157.jpg
OZAWADE Emerges as the New Therapeutic Hope for Obstructive Sleep Apnea in Major Markets
29 avr. 2024 10h40 HE | Research and Markets
Dublin, April 29, 2024 (GLOBE NEWSWIRE) -- The "OZAWADE Market Size, Forecast, and Market Insight - 2032" report has been added to ResearchAndMarkets.com's offering.A revolutionary treatment for...
22157.jpg
Budesonide for Primary Biliary Cholangitis (PBC) in 8MM: Market Size, Forecasts, and Drug Insights 2032 - Focus on United States, Germany, France, Italy, Spain, United Kingdom, Japan, and China
29 avr. 2024 10h32 HE | Research and Markets
Dublin, April 29, 2024 (GLOBE NEWSWIRE) -- The "Budesonide Market Size, Forecast, and Drug Insight - 2032" report has been added to ResearchAndMarkets.com's offering.The report provides...